Inventor · disambiguated record
Daniel Genov
Also filed as: GENOV DANIEL · GENOV DANIEL G
18 granted patents·2 pending applications·117 citations·filing 2005–2024
94Inventor score
Files withINFINITY PHARMACEUTICALS INC6THERAVANCE INC5FATHEREE PAUL R3MARQUESS DANIEL3GENOV DANIEL G2
Top patents by PatentIndex Score
20 records- 0197US7375114B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted May 20, 2008·41 cites·17 claims
- 0292US9394313B2Transfer hydrogenation of cyclopamine analogsGENOV DANIEL G·Filed 2011·Granted Jul 19, 2016·12 cites·24 claims
- 0392US9376447B2Transfer hydrogenation of cyclopamine analogsGENOV DANIEL G·Filed 2011·Granted Jun 28, 2016·12 cites·19 claims
- 0492US7763637B2Quinolinone-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jul 27, 2010·12 cites·19 claims
- 0590US9879025B2Transfer hydrogenation of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·3 cites·13 claims
- 0688US11247995B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2018·Granted Feb 15, 2022·2 cites·44 claims
- 0787US8962653B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2013·Granted Feb 24, 2015·5 cites·11 claims
- 0886US8163920B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2010·Granted Apr 24, 2012·5 cites·4 claims
- 0986US7728004B2Crystalline form of a quinolinone-carboxamide compoundTHERAVANCE INC·Filed 2006·Granted Jun 1, 2010·6 cites·7 claims
- 1084US8658671B2Crystalline form of a quinolinone-carboxamide compoundFATHEREE PAUL R·Filed 2010·Granted Feb 25, 2014·5 cites·6 claims
- 1184US8309575B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2010·Granted Nov 13, 2012·5 cites·5 claims
- 1282US12384792B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameTWELVE THERAPEUTICS INC·Filed 2024·Granted Aug 12, 2025·0 cites·9 claims
- 1382US9481667B2Salts and solid forms of isoquinolinones and composition comprising and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·4 cites·35 claims
- 1481US11939333B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2022·Granted Mar 26, 2024·0 cites·18 claims
- 1581US10160761B2Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Dec 25, 2018·2 cites·43 claims
- 1673US9402840B2Crystalline form of a quinolinone-carboxamide compoundFATHEREE PAUL R·Filed 2015·Granted Aug 2, 2016·1 cites·12 claims
- 1773US9126994B2Crystalline form of a quinolinone-carboxamide compoundFATHEREE PAUL R·Filed 2014·Granted Sep 8, 2015·1 cites·15 claims
- 1872US7671198B2Process for preparing intermediates to 5-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2007·Granted Mar 2, 2010·1 cites·13 claims
- 1944US2016024051A1Salts and solid forms of isoquinolinones and composition comprising and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2044US2006183901A1Crystalline form of an indazole-carboxamide compoundTHERAVANCE INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel Genov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →